Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Dutasteride and finasteride affect different cell types differently.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

New drug shows promise for better hair growth in baldness treatment.

Oestrogens are key for bone growth during puberty in both boys and girls.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

New compounds may soon be tested to treat excessive hair growth in women.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.